Literature DB >> 33455806

Repeat serial transverse enteroplasty procedure (reSTEP): Is it worth it?

Caroline Lemoine1, Kevin Larkin1, Katherine Brennan2, Carmyn Zoller-Thompson2, Valeria Cohran2, Riccardo Superina3.   

Abstract

BACKGROUND: The utility of repeat serial transverse enteroplasty (reSTEP) has been questioned after patients failed to achieve enteral autonomy. We compared the outcomes after reSTEP to one lifetime STEP (oneSTEP), and tried to identify patients at risk for reSTEP failure.
METHODS: All STEPs done at our institution were reviewed. Growth, enteral autonomy, bowel-derived bloodstream infection hospital admissions, complications, and need for bowel transplantation were evaluated (p<0.05 considered significant).
RESULTS: 24 patients underwent 32 STEP (16 oneSTEP, 8 reSTEP). reSTEP patients were younger at first surgery (1.01±1.05 vs. oneSTEP 3.06±4.73 years, p = 0.24). Median time to reSTEP was 1.1 year (0.6-5.7). Weight-for-length z-scores improved after reSTEP (0.02±1.40 to 0.22±1.42, p = 0.81). Bowel-derived bloodstream infections decreased after surgery (oneSTEP 1.50±2.25 to 0.94±1.73, p = 0.50; reSTEP 1.88±2.10 to 1.66±2.32, p = 0.52). 37.5% (9/24) patients achieved enteral autonomy at last follow-up: 7/16 oneSTEP, 2/8 reSTEP (p = 0.37). Two complications occurred after oneSTEP (staple line ulcer, leak), none following reSTEP. Three patients (oneSTEP 1/16, reSTEP 2/8, p = 0.19) underwent bowel transplantation (all gastroschisis).
CONCLUSION: Similar postoperative outcomes after reSTEP and single STEP (improved enteral tolerance, reduced rates of infections) support the use of reSTEP when clinically indicated, although reSTEP in young infants with a history of gastroschisis may need further evaluation.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Bowel transplantation; Bowel-derived bloodstream infection; Complications; Enteral autonomy & tolerance; Growth; Level of evidence: III; Serial transverse enteroplasty procedure

Mesh:

Year:  2021        PMID: 33455806     DOI: 10.1016/j.jpedsurg.2020.12.026

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  3 in total

1.  Serial transverse enteroplasty (STEP) in case of short bowel syndrome: did we achieve our goal? A systematic review.

Authors:  A Lauro; A Santoro; R Cirocchi; M Michelini; N Zorzetti; M C Cianci; M I Bellini; C Casadei; M C Ripoli; R Coletta; S Khouzam; I R Marino; V D'Andrea; A Morabito
Journal:  Updates Surg       Date:  2022-07-08

Review 2.  Comparing bowel lengthening procedures: which, when, and why?

Authors:  Jasper B van Praagh; H Sijbrand Hofker; Jan-Willem Haveman
Journal:  Curr Opin Organ Transplant       Date:  2022-04-01       Impact factor: 2.640

Review 3.  Surgical Treatment of Short Bowel Syndrome-The Past, the Present and the Future, a Descriptive Review of the Literature.

Authors:  Julian L Muff; Filipp Sokolovski; Zarah Walsh-Korb; Rashikh A Choudhury; James C Y Dunn; Stefan G Holland-Cunz; Raphael N Vuille-Dit-Bille
Journal:  Children (Basel)       Date:  2022-07-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.